Kline Confirms that Excipients are on the Rise in a New Era for Biologics and Topicals


The global pharmaceutical industry is facing a surge biologics. In recent years, biologic drugs have enjoyed a better approval rating than traditional drugs, as biologic drugs have been found to treat major chronic and complex diseases with higher safety and efficacy. The global production of biologics is expected to grow at a rate of around 10% annually.Continue reading

Solubility enhancement in pharmaceutical oral solid dosage forms

Three Key Trends in the Solubility Enhancement Industry

With approximately 90% of the active pharmaceutical ingredients that are under development falling into the two low solubility classes of the Biopharmaceutical Classification System (BCS), solubility enhancement technologies represent a strongly growing need for the pharmaceutical industry globally. Our current research covering solubility enhancement technologies and the related excipients market forecasts a compound annual growth rate (CAGR) of over 10% in the period from 2014 to 2024 for this highly important segment, driven by the demand for solubility enhancement excipients. Continue reading